Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation
Mingjun Zheng, Yuexin Hu, Rui Gou, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109810-109810
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer
Yongjia Cui, Weixuan Zhang, Wenping Lü, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway
Hui Liu, Ling Zhang, Xiaoling Ding, et al.
Molecular Medicine Reports (2020) Vol. 23, Iss. 1, pp. 1-1
Open Access | Times Cited: 46
Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA
Yize Li, Hongyan Peng, Peng Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Identification and Validation of an m7G-Related lncRNAs Signature for Prognostic Prediction and Immune Function Analysis in Endometrial Cancer
Jiani Sun, Li Li, Hong Chen, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1301-1301
Open Access | Times Cited: 19
Identification of long noncoding RNAs downregulated specifically in ovarian high‐grade serous carcinoma
Maki Hayashi‐Okada, Shun Sato, Kengo Nakashima, et al.
Reproductive Medicine and Biology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications
Sneha Basu, Revathy Nadhan, Danny N. Dhanasekaran
Cancers (2025) Vol. 17, Iss. 3, pp. 472-472
Open Access
Long non-coding RNAs: A view to kill ovarian cancer
Alexey V. Zamaraev, Pavel I. Volik, Г. Т. Сухих, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188584-188584
Open Access | Times Cited: 26
Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26
De novo assembly and transcriptome characterization: Novel insights into the mechanisms of primary ovarian cancer in Microtus fortis
Qi Hu, Mingyue Gao, Du Zhang, et al.
Molecular Medicine Reports (2021) Vol. 25, Iss. 2
Open Access | Times Cited: 25
Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics
Mengyu Chen, Ningjing Lei, Wanjia Tian, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 16
Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer
Neetu Tyagi, Shikha Roy, Vengadesan Krishnan, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 66-75
Open Access | Times Cited: 10
Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
Weihao Kong, Xingyu Wang, Xiaomin Zuo, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 26
Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning
Chen Zhao, Kewei Xiong, Fangrui Zhao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 15
LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p/PEG3 axis
Wenhong Fang, Yufang Xia
Anti-Cancer Drugs (2022) Vol. 33, Iss. 7, pp. 671-681
Closed Access | Times Cited: 14
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
Rui Geng, Tian Chen, Zihang Zhong, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4056-4056
Open Access | Times Cited: 14
<p>LEMD1-AS1 Suppresses Ovarian Cancer Progression Through Regulating miR-183-5p/TP53 Axis</p>
Ruowen Guo, Yide Qin
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7387-7398
Open Access | Times Cited: 20
Prognostic prediction and expression validation of NSD3 in pan-cancer analyses
SHA LI, YAQIONG LIU, CHAOLING YAO, et al.
Biocell (2023) Vol. 47, Iss. 5, pp. 1003-1019
Open Access | Times Cited: 6
Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
Sen Guo, Jianru Chen, Xiuli Yi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma
Yuan Fang, Yang Yang, Xiaoli Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data
Jian Zhang, Chi Huang, Guiqi Zhu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 9
Long Noncoding RNAs in Ovarian Cancer—Functions and Clinical Applications
Lili Zhong, Xin Li, Yicun Wang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 4
Open Access | Times Cited: 5
Gestational Age Dependence of the Maternal Circulating Long Non-Coding RNA Transcriptome During Normal Pregnancy Highlights Antisense and Pseudogene Transcripts
Erica L. Kleinbrink, Nardhy Gómez-López, Donghong Ju, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 12
Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC
Jinfeng Ning, Fengjiao Wang, Kaibin Zhu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 12
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer
Min Zhou, Tao Wu, Yuan Yuan, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Lidia Lorenzo-Catoira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10798-10798
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top